# Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

> **NCT00424203** · PHASE2 · COMPLETED · sponsor: **UNICANCER** · enrollment: 40 (actual)

## Conditions studied

- Breast Cancer
- Cognitive/Functional Effects
- Depression
- Malnutrition
- Psychosocial Effects of Cancer and Its Treatment

## Interventions

- **DRUG:** AC regimen
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** cognitive assessment
- **PROCEDURE:** management of therapy complications
- **PROCEDURE:** psychosocial assessment and care
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00424203
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-01
- **Final completion:** 2011-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424203, "Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00424203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*